## A: Agilent Technologies, Inc. - XLV: Healthcare

### Executive Summary

No thesis match: MRS_10 -2.1% below STRENGTH zone (3.0-6.0%); PEG 2.23 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($130.33)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 6, Bearish: 0)

**1. Agilent Technologies (NYSE:A) Is Increasing Its Dividend To $0.255**
- Source: Simply Wall Street | 20251218T101958 | Bullish | Relevance: 100%
- Agilent Technologies (NYSE:A) is raising its dividend to $0.255, resulting in a 0.7% yield which is above the industry average. The company's earnings are expected to grow by 46.1% next year, covering the dividend with a projected payout ratio of 16%. Agilent has a solid track record of increasing dividends, growing them at 9.8% per annum over the last decade, making it an attractive income stock.

**2. Agilent Technologies (NYSE:A) Is Increasing Its Dividend To $0.255**
- Source: Simply Wall Street | 20251218T100749 | Bullish | Relevance: 100%
- Agilent Technologies (NYSE:A) has announced an increase in its dividend to $0.255, resulting in a dividend yield of 0.7%, which is above the industry average. The company's earnings easily cover the dividend, with a projected payout ratio of 16%, suggesting strong sustainability. Agilent Technologies also boasts a solid track record of dividend growth and consistent EPS growth, making it an attractive income stock.

**3. What's Driving the Market Sentiment Around Agilent Technologies Inc?**
- Source: Sahm | 20251218T011019 | Somewhat-Bullish | Relevance: 100%
- Agilent Technologies Inc's short interest as a percent of float has decreased by 13.82% since its last report, now standing at 1.31% of available shares. This decline in short interest suggests a more bullish sentiment from investors. Compared to its peers, Agilent Technologies Inc has less short interest, with the peer group average at 7.67%.

**4. Agilent Technologies opens India Refurbishment Center to advance sustainable science and affordable innovation**
- Source: Pharmabiz.com | 20251217T100731 | Bullish | Relevance: 100%
- Agilent Technologies has opened its India Refurbishment Center in Manesar, Haryana, aiming to provide Certified Pre-Owned (CPO) instruments to support sustainable science and affordability in India. This center, along with a new India Education Center, will offer high-quality, cost-effective solutions, advanced training, and flexible financing options to laboratories, reinforcing Agilent's commitment to the Indian market. The initiative also promotes circular economy principles by offering trade-in and buyback programs for used instruments.

**5. Agilent Technologies opens India Refurbishment Centre in Manesar**
- Source: BioSpectrum India | 20251217T091322 | Bullish | Relevance: 100%
- Agilent Technologies has inaugurated its India Refurbishment Centre in Manesar, Haryana, enhancing its commitment to sustainable science and affordability in India. This center will provide Certified Pre-Owned instruments and hands-on training through an associated India Education Centre. The initiative aims to support laboratories with cost-effective, high-quality solutions and integrate sustainable practices into the market.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 7, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-15 | Barclays | $165 | $165 | 0% |
| 2025-12-09 | Goldman Sachs | $170 | $0 | 0% |
| 2025-12-02 | Morgan Stanley | $180 | $0 | 0% |
| 2025-11-25 | Citigroup | $185 | $165 | +12% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-15 | Barclays | up | Overweight |
| 2025-12-09 | Goldman Sachs | init | Buy |
| 2025-12-02 | Morgan Stanley | init | Overweight |
| 2025-11-25 | Citigroup | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 10 ($1.37M) |
| Sells | 18 ($1.60M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 44.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 12.0% (+0.1%)
- Blackrock Inc.: 9.2% (+1.0%)
- Massachusetts Financ: 4.4% (-6.0%)
- State Street Corpora: 4.4% (-0.1%)
- Wellington Managemen: 3.3% (+4.8%)

### Key Risks

1. Near-term weakness: 5.4% below SMA50 despite long-term uptrend.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 7 raises (avg +12%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 2.23 elevated, pricing in significant growth expectations. Forward P/E 20.9x stretched relative to 10% growth. Quality metrics strong (ROE 21%, margin 19%). Analyst sentiment positive (7 raises, avg +12%). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $38.9B |
| Beta | 1.27 |
| 52W Range | $96.43 - $160.27 |
| Short Interest | 1.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.23 |
| Forward P/E | 20.9 |
| Current P/E | 23.1 |
| YoY Growth | 10.3% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from -0.8% to -2.1% (-1.3% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.1pp (needs >3.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.10x) but short-term weakness (below SMA20). MACD histogram bearish (-1.26), momentum weakening. OFD pattern: -SLH (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -2.11% (CS: 21) | Weak |
| RSI_14 | 36.3 | Neutral |
| MACD Histogram | -1.26 | Bearish |
| vs SMA20 | 0.943x | Below |
| vs SMA50 | 0.946x | Below |
| vs SMA200 | 1.103x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $137.21
- **Stop Loss:** $130.33 (5.0% risk)
- **Target:** $144.09 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 174
- **Position Value:** $23,874.54
- **Portfolio %:** 23.87%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with improving risk appetite as VIX falls to 6th percentile and tech rally resumes on AI infrastructure demand. Fed pause expectations from cooling CPI data support equities, though elevated put/call ratio suggests cautious positioning. Focus on quality names in AI-exposed sectors.*

### Earnings

**Next:** 2026-02-25 (Est: $1.37)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $1.58 | $1.59 | +0.4% |
| 2025Q3 | $1.37 | $1.37 | +0.2% |
| 2025Q2 | $1.26 | $1.31 | +3.6% |
| 2025Q1 | $1.27 | $1.31 | +3.0% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*